Hepatitis B: all 1,662 studies
Page 12 of 17. Open to participants first (192), then studies with results posted, then the rest; newest registration first within each.
- Clinical Efficacy of ABX203 Therapeutic Vaccine in HBeAg Negative Patients With Chronic Hepatitis BCompletedNCT02249988Phase 2/3
- Follow-up of HBsAg Inactive Carriers StudyCompletedNCT02247752Not applicable
- Traditional Chinese Medicine Combined With Entecavir to Treat Refractory Liver Fibrosis in Liver Cirrhosis Due to HBVStatus unknownNCT02241616Phase 4
- Treatment of Liver Cirrhosis Due to Hepatitis B Virus With Fuzheng Huayu and EntecavirStatus unknownNCT02241590Phase 4
- A Trial Comparing Entacavir and Tenofovir in Patients With HBV Decompensated CirrhosisStatus unknownNCT02238860Phase 4
- REP 2139-Ca / Pegasys™ Combination Therapy in Hepatitis B / Hepatitis D Co-infectionCompletedNCT02233075Phase 2
- Oxymatrine Plus Lamivudine Combination Therapy Versus Lamivudine Monotherapy for Chronic Hepatitis B Infected SubjectsCompletedNCT02202473Phase 4
- An Observational Study in Participants With Chronic Hepatitis B (CHB) Receiving Therapy With Peginterferon Alfa-2a 40 Kilodaltons (kD) (PEGASYS) - The PRO B StudyCompletedNCT02201407
- Rapid Diagnostics for HIV and HepatitisWithdrawnNCT02190305Not applicable
- Proof Of Concept : Immunogenicity and Safety of hepB Injection in the Dermis Using VAX-IDCompletedNCT02186977Phase 1
- Tenofovir to Prevent HBV ReactivationStatus unknownNCT02186574Phase 3
- Observational Study on Patients With Chronic Hepatitis BStatus unknownNCT02167503
- Collection of Samples for the Clinical Evaluation of the Aptima HBV (Hepatitis B Virus) Quant (Quantification) AssayCompletedNCT02167113
- Immune Response to Hepatitis B Virus Booster Vaccination After 20-23 YearsTerminatedNCT02166671Not applicable
- Study to Evaluate the Persistence of the Cellular and Humoral Immune Response Following Vaccinations With GlaxoSmithKline (GSK) Biologicals' Candidate Vaccines Containing HBsAg and Different Adjuvants in Healthy Adult VolunteersCompletedNCT02153320Phase 1
- Study of Evaluating Safety and Immunogenicity of 10µg/0.5ml Hepatitis B VaccineCompletedNCT02152709Phase 3
- Assessment of Hepatitis B Virus Intra-host Population and Host-specific Immune Marker DiversityStatus unknownNCT02148562
- Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid TumorsCompletedNCT02143401Phase 1
- Patient-Centered Care and Asian AmericansCompletedNCT02139722Not applicable
- Evaluation of the Long-term Hepatitis A and B Antibody Persistence in Healthy Adult Subjects, Primed 16 to 20 Years Earlier With GSK Biologicals' Combined Hepatitis A and B Vaccine, Twinrix® (SB208127) in Study HAB-084 (208127/084)WithdrawnNCT02135666Phase 4
- PROLIFICA - West African Treatment Cohort for Hepatitis BCompletedNCT02129829
- Prevalence and Clinical Course of Chronic Hep B Infection in IBD and Rheumatologic DiseaseTerminatedNCT02128503Not applicable
- Study on the Pharmacokinetic Characteristics of I.V. Hepabig Injection Used for Prevention of Hepatitis B Relapse After Liver TransplantationCompletedNCT02125071
- Study to Assess Seroprevalence of Hepatitis A, Hepatitis B and Bordetella Pertussis in MexicoCompletedNCT02112890
- Safety and Efficacy Study of NVR 3-778 in Healthy Volunteers and Hepatitis B PatientsCompletedNCT02112799Phase 1
- Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma PatientsCompletedNCT02108444
- Study of Therapeutic Vaccination With Intensified Schedule Plus Pegasys Dual Therapy on Chronic Hepatitis B InfectionCompletedNCT02097004Phase 4
- DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed InfantsCompletedNCT02094833Phase 3
- Prophylaxis of CHB Patients With Malignant Tumor Receiving ChemotherapyCompletedNCT02081469Phase 4
- Efficacy and Safety Study of Adefovir and Entecavir for Elderly With Chronic Hepatitis BCompletedNCT02075294
- Serum Hepatitis B Surface Antigen Levels to Guide the Stopping of Entecavir in HBeAg-negative Chronic Hepatitis BCompletedNCT02069678
- An Open-label Trial of 48-week Peginterferon Alfa-2a (PEGASYS) to Assess the Sustained Response of Chronic Hepatitis B Patients With HBeAg Seroconversion on Nucleot(s)Ide Analogue TherapyCompletedNCT02068365Phase 4
- Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern AfricaCompletedNCT02060162
- The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy AdultsCompletedNCT02057263Phase 1
- Hepatitis B Virus Reactivation After Withdrawal of Preemptive Antiviral Therapy in Hematologic MalignancyStatus unknownNCT02056548
- Abatacept vs Placebo in RA Patients With Hepatitis B on Entecavir BackgroundWithdrawnNCT02053727Not applicable
- Effect of Telbivudine on Renal Function and Proteinuria in Patients With CHB & Chronic Renal DiseasesWithdrawnNCT02049736Not applicable
- Hepatitis B Antigen Kidney Graft Into Protective Level Hepatitis B Antibody RecipientsStatus unknownNCT02044588
- Noninvasive Staging of Liver Fibrosis: MR vs UltrasoundCompletedNCT02044523
- Hepatitis B Virus Vertical Transmission From HIV-HBV Co-infected WomenCompletedNCT02044068
- Study of Tetanus and Diphtheria Toxoids Adsorbed Combined With Component Pertussis Vaccine and Inactivated PoliomyelitisCompletedNCT02040636Phase 2
- Prevention of Hepatitis B Virus Vertical Transmission by Serovaccination and Tenofovir During PregnancyCompletedNCT02039362Phase 4
- The Effect of General Anesthesia Immunosuppressive on Hepatitis B Virus ReplicationCompletedNCT02038088
- A Study to Characterise Immune Responses Following Immunisations With "Fendrix" or "Engerix B" Hepatitis B VaccinesCompletedNCT02032160Not applicable
- Prospective Cohort Study of Association of Insulin Resistance/Steatosis With Hepatic Fibrosis in CHB and NAFLDCompletedNCT02031913
- Hepatitis B Virus HBeAg-negative Genotype D Patients and Hepatocellular CarcinomaCompletedNCT02025842
- A Korean Cohort Study of TDF Rescue Therapy for Difficult-to-treat CHB Patients: a Comparison Between TDF Monotherapy and TDF-based Combination TherapyCompletedNCT02019966
- Procurement of Blood Samples for a Biomedical Research Program on T Cell Functional Response to Chronic HBV InfectionStatus unknownNCT02017587
- Study of the Immunogenicity and Safety of a Challenge Dose of HBVAXPRO in Healthy Children Vaccinated 10 Years Ago With 3 Doses of HEXAVAC or INFANRIX HEXACompletedNCT02012998Phase 3
- Retrospective Observational Study to Define HBsAg Loss With or Without Seroconversion to antiHBs in Patients With Chronic Hepatitis by B Virus Treated With Nucleoside/Nucleotide AnalogsCompletedNCT02005146
- Comparative Efficacy of an Intensified Re-vaccination Scheme for Hepatitis B Virus Infection Among Patients Infected With HIV .CompletedNCT02003703Phase 3
- A Study of the Immune Response to Heplisav in Healthy Older AdultsCompletedNCT01999699Phase 1
- Efficacy and Safety of S-adenosyl-L-methionine in Treatment of Chronic Hepatitis B Patients With CholestasisStatus unknownNCT01998620Phase 4
- Recombinant Human Serum Albumin/Interferon alpha2a Fusion Protein Phase Ib Study in Chronic Hepatitis B PatientsCompletedNCT01997944Phase 1/2
- Non-invasive Biomarkers of Fibrosis in Pediatric Liver DiseasesCompletedNCT01988753
- Observation Study of Prednisone and Cyclosporine in Treatment of Thrombocytopenia in Hepatitis B CirrhosisStatus unknownNCT01987791
- Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa VaccinationCompletedNCT01983540Phase 3
- The Safety and Immunogenicity of DTP/Hepatitis B 10ug Hib Vaccine (Bio Farma)CompletedNCT01977196Phase 1
- Hepatitis B Seroepidemiology Among Young AdultsStatus unknownNCT01973582
- Widespread vs. Selective Screening for Hepatitis B Infection Prior to ChemotherapyCompletedNCT01970254
- A Clinical Evaluation on Traditional Chinese Medicine Diagnosis and Treatment Program Blocking and Reversing Hepatitis B-related Liver Fibrosis - a Randomized, Controlled, Double-blind, Multi-center Clinical TrialStatus unknownNCT01965418Phase 4
- Prospective Stuy in Evaluating Hepatic Fibrosis Related to Hepatitis B Virus Using Non-invasive ParametersCompletedNCT01962155
- Efficacy Study of Telbivudine in Chronic Hepatitis B PatientsCompletedNCT01958229
- The Follow-up Study of Chronic Hepatitis B Patients With Liver Cirrhosis Receiving Anti-HBV TherapyStatus unknownNCT01957618
- Therapeutic Option for Hepatitis B and C: a French CohortStatus unknownNCT01953458
- Safety and Efficacy Study of Adjuvanted Prophylactic Hepatitis B VaccineCompletedNCT01951677Phase 1
- Phase 3 and Extensional Study of BesifovirStatus unknownNCT01937806Phase 3
- A Clinical Trial on HB-Vac Activated-DCs Combined With Peg-IFN or NAs in CHBCompletedNCT01935635Phase 1/2
- Efficacy and Safety of Hepatitis B Vaccine in Chronic Kidney Disease PatientsStatus unknownNCT01933412Phase 3
- At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsCompletedNCT01931644
- Efficacy of Switching or Adding Pegylated Interferon in Chronic Hepatitis B Patients on Long Term Oral Antiviral TherapyCompletedNCT01928511Phase 4
- Efficacy and Safety of Entecavir Maleate Tablets in Chinese Patients With Hepatitis BCompletedNCT01926288Phase 4
- Pegasys Plus Entecavir Versus Entecavir Versus Pegasys for Hepatitis B e Antigen-Negative Chronic Hepatitis BStatus unknownNCT01925820Phase 4
- HBV-HIV Coinfection Research NetworkCompletedNCT01924455
- A Comparison of the Immunogenicity and Safety of Quinvaxem in Mono-dose Vials and UnijectCompletedNCT01917357Phase 3
- Entecavir Versus Lamivudine for Preventing the Risk of Hepatitis B Reactivation in NHLStatus unknownNCT01914744Phase 2
- Baracle Tab. ® Versus Baraclude Tab.® for Patients With HBeAg Chronic Hepatitis BCompletedNCT01913431Phase 4
- Sustained Off-treatment Response After HBeAg Loss in Chronic Hepatitis B Patients Treated With Nucleos(t)Ide AnaloguesStatus unknownNCT01911156Phase 4
- Hepatic Safety of Currently Used Antiretroviral Regimens in Patients With Chronic Hepatitis Under Real Life ConditionsCompletedNCT01908660
- Entecavir for Biological Agents Associated HBV Reactivation in Inflammatory Arthritis PatientsStatus unknownNCT01907230Phase 4
- Combination or Sequential Therapy of Peginterferon Alfa-2a and Entecavir for Patients With Chronic Hepatitis BStatus unknownNCT01906580Phase 4
- A Phase III Study to Assess the Immunogenicity and Safety of Eutravac (DTap-HB Combined Vaccine) With DTaP and Hepatitis B Vaccines in Healthy InfantsCompletedNCT01896739Phase 3
- Hepatitis B Vaccination in InfantsCompletedNCT01896596Phase 4
- Efficacy and Safety of Peginterferon a-2a in Patients of Chronic Hepatitis B With Spontaneous Decline of HBV DNACompletedNCT01892241Phase 3
- A Control Study to Evaluate The Efficacy And Safety of Ozone-therapy in Chronic Hepatitis BCompletedNCT01887275Phase 4
- Phase III, Study to Evaluate the Efficacy of Two Different HBV Vaccination Schemes in Patients With Hepatic CirrhosisCompletedNCT01884415Phase 3
- The Treatment With HBIG+GM-CSF+HBV Vaccine for Chronic Hepatitis B Patients With HBeAg SeroconversionStatus unknownNCT01878565Phase 1/2
- Randomized Controlled Trial of the Impact of Mobile Phone Delivered Reminders and Travel Subsidies to Improve Childhood Immunization Coverage Rates and Timeliness in Western KenyaCompletedNCT01878435Not applicable
- Tenofovir Antiviral Therapy Following Transarterial Chemoembolization for HBV Related Hepatocellular CarcinomaTerminatedNCT01872988Phase 3
- Drug Use Investigation for HEPSERA (Adefovir) TabletCompletedNCT01863589
- Seroprevalence of Hepatitis B and Immune Response to Hepatitis B Vaccination in Chinese College StudentsCompletedNCT01861613Phase 4
- A Clinical Trial of Zutectra in Patients Who Recently Received a Liver TransplantCompletedNCT01856413Phase 3
- Tenofovir Versus Lamivudine for Patients of Chronic Hepatitis B With Severe Acute ExacerbationStatus unknownNCT01848743Phase 3
- UCLA-Amity Parolee Health Promotion StudyCompletedNCT01844414Not applicable
- 3E Extension StudyStatus unknownNCT01834508Phase 4
- Entecavir for Chronic Hepatitis B Patients With Persistently Normal ALTStatus unknownNCT01833611Phase 4
- The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) StudyWithdrawnNCT01831037
- Efficacy Optimizing Extension Study of Chronic Hepatitis B Patients With Inadequate Response to NUC TherapyStatus unknownNCT01829685Phase 4
- Study of the Model to Predict 3-month Mortality Risk of Acute-on-chronic Hepatitis B Liver FailureCompletedNCT01826760
- New Methods to Measure the Immune Response to Hepatitis B VaccineCompletedNCT01821547Phase 4